Our findings have shown both CCL18 and SP‐D are predictors of 3‐year mortality but not overall mortality (analysed by time‐to‐event), suggesting these molecules reflect the onset of decline in IPF. Here, SFTPD is linked to idiopathic pulmonary fibrosis.